Montelukast Modulates MPTP-induced Ferroptosis and Neuroinflammation Linked To the GPX4/ACSL4/5-LOX Pathway

Chen, L., Hambright, W. S., Na, R., & Ran, Q. (2015). Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. The Journal of Biological Chemistry, 290(47), 28097–28106. https://doi.org/10.1074/jbc.M115.680090

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen, B., Wen, X., Jiang, H., Wang, J., Song, N., & Xie, J. (2019). Interactions between iron and α-synuclein pathology in parkinson’s disease. Free Radical Biology & Medicine, 141, 253–260. https://doi.org/10.1016/j.freeradbiomed.2019.06.024

Article  CAS  Google Scholar 

Czapski, G. A., Czubowicz, K., & Strosznajder, R. P. (2012). Evaluation of the antioxidative properties of lipoxygenase inhibitors. Pharmacological Reports, 64(5), 1179–1188. https://doi.org/10.1016/s1734-1140(12)70914-3

Article  CAS  PubMed  Google Scholar 

Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., Morrison, B., & Stockwell, B. R. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060–1072. https://doi.org/10.1016/j.cell.2012.03.042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., Prokisch, H., Trümbach, D., Mao, G., Qu, F., Bayir, H., Füllekrug, J., Scheel, C. H., Wurst, W., Schick, J. A., Kagan, V. E., Angeli, J. P., & Conrad, M. (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology, 13(1), 91–98. https://doi.org/10.1038/nchembio.2239

Article  CAS  PubMed  Google Scholar 

Fernández-Mendívil, C., Luengo, E., Trigo-Alonso, P., García-Magro, N., Negredo, P., & López, M. G. (2021). Protective role of microglial HO-1 Blockade in aging: Implication of iron metabolism. Redox Biology, 38, 101789. https://doi.org/10.1016/j.redox.2020.101789

Article  CAS  PubMed  Google Scholar 

Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T., & Surmeier, D. J. (2010). Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature, 468(7324), 696–700. https://doi.org/10.1038/nature09536

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013). Biological markers of oxidative stress: Applications to cardiovascular research and practice. Redox Biology, 1(1), 483–491. https://doi.org/10.1016/j.redox.2013.07.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003). Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson’s disease brains. Acta Neuropathologica, 106(6), 518–526. https://doi.org/10.1007/s00401-003-0766-2

Article  CAS  PubMed  Google Scholar 

Jang, H., Kim, S., Lee, J. M., Oh, Y. S., Park, S. M., & Kim, S. R. (2017). Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of parkinson’s disease. Neuroreport, 28(5), 242–249. https://doi.org/10.1097/wnr.0000000000000740

Article  CAS  PubMed  Google Scholar 

Jankovic, J., & Tan, E. K. (2020). Parkinson’s disease: Etiopathogenesis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 91(8), 795–808. https://doi.org/10.1136/jnnp-2019-322338

Article  PubMed  Google Scholar 

Jian, X., Zhao, G., Chen, H., Wang, Y., Li, J., Xie, L., & Li, B. (2022). Revealing a novel contributing landscape of ferroptosis-related genes in Parkinson’s disease. Computational and Structural Biotechnology Journal, 20, 5218–5225. https://doi.org/10.1016/j.csbj.2022.09.018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jyotsana, N., Ta, K. T., & DelGiorno, K. E. (2022). The role of Cystine/Glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer. Frontiers in Oncology, 12, Article 858462. https://doi.org/10.3389/fonc.2022.858462

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, J., Cao, F., Yin, H. L., Huang, Z. J., Lin, Z. T., Mao, N., Sun, B., & Wang, G. (2020). Ferroptosis: Past, present and future. Cell Death & Disease, 11(2), Article 88. https://doi.org/10.1038/s41419-020-2298-2

Article  Google Scholar 

Li, T., Liu, J., Huang, X., Xie, Y., Hu, Y., Xu, Q., Tang, B., Tan, J., & Guo, J. (2025). Deficiency of PLA2G6 induces ferroptosis in dopaminergic neurons and contributes to parkinson’s disease pathogenesis via disruption of PRDX6/FTH1/GPX4 axis. Molecular Neurobiology. https://doi.org/10.1007/s12035-025-05257-x

Article  PubMed  PubMed Central  Google Scholar 

Liu, Y., Wang, W., Li, Y., Xiao, Y., Cheng, J., & Jia, J. (2015). The 5-lipoxygenase inhibitor Zileuton confers neuroprotection against glutamate oxidative damage by inhibiting ferroptosis. Biological & Pharmaceutical Bulletin, 38(8), 1234–1239. https://doi.org/10.1248/bpb.b15-00048

Article  CAS  Google Scholar 

Mansour, R. M., Ahmed, M. A. E., El-Sahar, A. E., & El Sayed, N. S. (2018). Montelukast attenuates rotenone-induced microglial activation/p38 MAPK expression in rats: Possible role of its antioxidant, anti-inflammatory and antiapoptotic effects. Toxicology and Applied Pharmacology, 358, 76–85. https://doi.org/10.1016/j.taap.2018.09.012

Article  CAS  PubMed  Google Scholar 

Marques, C. F., Marques, M. M., & Justino, G. C. (2022). Leukotrienes vs. montelukast-Activity, metabolism, and toxicity hints for repurposing. Pharmaceuticals. https://doi.org/10.3390/ph15091039

Article  PubMed  PubMed Central  Google Scholar 

Marschallinger, J., Schäffner, I., Klein, B., Gelfert, R., Rivera, F. J., Illes, S., Grassner, L., Janssen, M., Rotheneichner, P., Schmuckermair, C., Coras, R., Boccazzi, M., Chishty, M., Lagler, F. B., Renic, M., Bauer, H.-C., Singewald, N., Blümcke, I., Bogdahn, U., … Aigner, L. (2015). Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nature Communications, 6(1), Article 8466. https://doi.org/10.1038/ncomms9466

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masaldan, S., Bush, A. I., Devos, D., Rolland, A. S., & Moreau, C. (2019). Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radical Biology & Medicine, 133, 221–233. https://doi.org/10.1016/j.freeradbiomed.2018.09.033

Article  CAS  Google Scholar 

Michael, J., Marschallinger, J., & Aigner, L. (2019). The leukotriene signaling pathway: A druggable target in Alzheimer’s disease. Drug Discovery Today, 24(2), 505–516. https://doi.org/10.1016/j.drudis.2018.09.008

Article  CAS  PubMed  Google Scholar 

Michael, J., Unger, M. S., Poupardin, R., Schernthaner, P., Mrowetz, H., Attems, J., & Aigner, L. (2020). Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer’s disease mice. Acta Neuropathologica Communications, 8(1), Article 129. https://doi.org/10.1186/s40478-020-00989-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nagarajan, V. B., & Marathe, P. A. (2018). Effect of Montelukast in experimental model of Parkinson’s disease. Neuroscience Letters, 682, 100–105. https://doi.org/10.1016/j.neulet.2018.05.052

Article  CAS  PubMed  Google Scholar 

Nussbaum, R. L., & Ellis, C. E. (2003). Alzheimer’s disease and Parkinson’s disease. The New England Journal of Medicine, 348(14), 1356–1364. https://doi.org/10.1056/NEJM2003ra020003

Article  CAS  PubMed  Google Scholar 

Ramires, R., Caiaffa, M. F., Tursi, A., Haeggström, J. Z., & Macchia, L. (2004). Novel inhibitory effect on 5-lipoxygenase activity by the anti-asthma drug Montelukast. Biochemical and Biophysical Research Communications, 324(2), 815–821. https://doi.org/10.1016/j.bbrc.2004.09.125

Article  CAS  PubMed  Google Scholar 

Riederer, P., Monoranu, C., Strobel, S., Iordache, T., & Sian-Hülsmann, J. (2021). Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease. Journal Of Neural Transmission, 128(10), 1577–1598. https://doi.org/10.1007/s00702-021-02414-z

Article  CAS  PubMed  PubMed Central 

Comments (0)

No login
gif